Vericel (VCEL) accounting officer sells 2,732 shares, exercises options

Rhea-AI Filing Summary

Vericel Corp’s Principal Accounting Officer Jonathan Siegal reported a same-day option exercise and share sale. On June 26, 2026, he exercised 2,500 stock options at $29.82 per share and sold a total of 2,732 common shares at $44.90 per share in open-market transactions.

Following these trades, he holds 886 common shares directly and 6,500 stock options that remain outstanding and exercisable through February 17, 2033. The filing notes the sales were made under a pre-arranged Rule 10b5-1 trading plan, indicating they were scheduled in advance.

Insider Trade Summary 10b5-1

Net Seller: 2,732 shares ($122,667)

Net Sell 4 txns

Insider SIEGAL JONATHAN

Role Principal Accounting Officer

Sold 2,732 shs ($123K)

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	2,500	$0.00	--
Sale	Common Stock	232	$44.90	$10K
Exercise	Common Stock	2,500	$29.82	$75K
Sale	Common Stock	2,500	$44.90	$112K

Holdings After Transaction: Stock Option (Right to Buy) — 6,500 shares (Direct, null); Common Stock — 886 shares (Direct, null)

Footnotes (1)

1. The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025. These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). These options, representing the right to purchase 9,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 17, 2023, which was one quarter after the date on which the option was granted.

Key Figures

Shares sold: 2,732 shares Sale price: $44.90 per share Options exercised: 2,500 shares +5 more

8 metrics

Shares sold 2,732 shares Common stock sold on June 26, 2026

Sale price $44.90 per share Open-market sale price for common stock

Options exercised 2,500 shares Stock options exercised into common stock

Option exercise price $29.82 per share Strike price of exercised stock options

Shares held after 886 shares Direct common stock holdings after transactions

Options remaining 6,500 options Stock options outstanding after exercise

Option expiration February 17, 2033 Expiration date of remaining stock options

Net share change -2,732 shares Net sell direction in transaction summary

Key Terms

Rule 10b5-1 trading plan, Employee Stock Purchase Plan, Stock Option (Right to Buy), Rule 16b-3(d), +1 more

5 terms

Rule 10b5-1 trading plan regulatory

"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted..."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Employee Stock Purchase Plan financial

"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions..."

An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy) ... representing the right to purchase 9,000 shares..."

Rule 16b-3(d) regulatory

"transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."

Rule 16b-3(d) is a narrow SEC safe-harbor that shields company insiders (officers, directors and large shareholders) from liability for short‑swing profits when their buys or sells of company stock are made under a pre-established, written plan or contract that removes the insider’s ability to time trades. For investors, this matters because it permits predictable, automated insider transactions — like scheduled sales for diversification or payroll withholding — without triggering forced disgorgement, so such planned trades are treated differently from opportunistic insider trading.

Rule 16b-3(c) regulatory

"transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."

An SEC rule that lets corporate insiders avoid automatic "short‑swing" profit recovery when they buy or sell their company’s stock under a pre‑approved, written plan that meets specific conditions. For investors, it matters because it clarifies when insider trades are treated as routine, reducing legal uncertainty and helping distinguish trades made for ordinary compensation or pre‑planned reasons from those that might signal opportunistic or timely insider advantage.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/30/2026 - 04:06 PM Accepted by SEC EDGAR 06/30/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SIEGAL JONATHAN

(Last) (First) (Middle)

25 BLUE SKY DRIVE

(Street)

BURLINGTON MASSACHUSETTS 01803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vericel Corp [ VCEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Principal Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/26/2026		S		232	D(1)	$44.9	886(2)	D
Common Stock	06/26/2026		M		2,500	A	$29.82	3,386(2)	D
Common Stock	06/26/2026		S		2,500	D(1)	$44.9	886(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$29.82	06/26/2026		M		2,500		(3)	02/17/2033	Common Stock	2,500	$0	6,500	D

Explanation of Responses:

1. The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025.

2. These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

3. These options, representing the right to purchase 9,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 17, 2023, which was one quarter after the date on which the option was granted.

	/s/ Sean Flynn, as Attorney-in-Fact for Jonathan Siegal	06/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Vericel (VCEL) report for Jonathan Siegal?

Vericel reported that Principal Accounting Officer Jonathan Siegal exercised 2,500 stock options and sold 2,732 common shares. The sales occurred in open-market trades at $44.90 per share, as part of a routine Form 4 insider transaction disclosure.

At what prices did the Vericel (VCEL) insider trades occur?

The Form 4 shows Siegal exercised stock options at $29.82 per share and sold common shares at $44.90 per share. These prices reflect the option strike level and the actual open-market sale price on the transaction date.

How many Vericel (VCEL) shares does Jonathan Siegal hold after the Form 4 trades?

After the reported transactions, Siegal directly holds 886 Vericel common shares. He also retains 6,500 stock options, giving him additional potential future equity exposure if those options are exercised before expiration.

Were the Vericel (VCEL) insider sales made under a Rule 10b5-1 plan?

Yes. A footnote explains that the sales were executed automatically under a Rule 10b5-1 trading plan adopted on December 10, 2025. Such plans pre-schedule trades, reducing the significance of short-term market timing for these insider sales.

What do the exercised Vericel (VCEL) stock options in the Form 4 represent?

The exercised options represent the right to buy 2,500 Vericel shares at $29.82 per share. A footnote notes these options were part of a 9,000-share grant that vests quarterly, contingent on continued service to the company.

When do Jonathan Siegal’s remaining Vericel (VCEL) stock options expire?

The remaining 6,500 Vericel stock options shown in the filing expire on February 17, 2033. This long-dated expiration allows an extended period during which Siegal can choose to exercise those options, subject to their vesting schedule.